Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

International uniform response criteria for multiple myeloma.

Durie BG, Harousseau JL, Miguel JS, Bladé J, Barlogie B, Anderson K, Gertz M, Dimopoulos M, Westin J, Sonneveld P, Ludwig H, Gahrton G, Beksac M, Crowley J, Belch A, Boccadaro M, Cavo M, Turesson I, Joshua D, Vesole D, Kyle R, Alexanian R, Tricot G, Attal M, Merlini G, Powles R, Richardson P, Shimizu K, Tosi P, Morgan G, Rajkumar SV; International Myeloma Working Group..

Leukemia. 2006 Sep;20(9):1467-73. Erratum in: Leukemia. 2007 May;21(5):1134. Leukemia. 2006 Dec;20(12):2220.

PMID:
16855634
2.

Multiple myeloma: new staging systems for diagnosis, prognosis and response evaluation.

Rajkumar SV, Buadi F.

Best Pract Res Clin Haematol. 2007 Dec;20(4):665-80. Review.

PMID:
18070712
3.

Multiple myeloma: charging toward a bright future.

Katzel JA, Hari P, Vesole DH.

CA Cancer J Clin. 2007 Sep-Oct;57(5):301-18. Review.

4.
5.

Recent advances in the management of multiple myeloma.

Kumar L, Verma R, Radhakrishnan VR.

Natl Med J India. 2010 Jul-Aug;23(4):210-8. Review.

PMID:
21192514
6.

International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma.

Rajkumar SV, Dimopoulos MA, Palumbo A, Blade J, Merlini G, Mateos MV, Kumar S, Hillengass J, Kastritis E, Richardson P, Landgren O, Paiva B, Dispenzieri A, Weiss B, LeLeu X, Zweegman S, Lonial S, Rosinol L, Zamagni E, Jagannath S, Sezer O, Kristinsson SY, Caers J, Usmani SZ, Lahuerta JJ, Johnsen HE, Beksac M, Cavo M, Goldschmidt H, Terpos E, Kyle RA, Anderson KC, Durie BG, Miguel JF.

Lancet Oncol. 2014 Nov;15(12):e538-48. doi: 10.1016/S1470-2045(14)70442-5. Review.

PMID:
25439696
7.

The evolving use of serum free light chain assays in haematology.

Pratt G.

Br J Haematol. 2008 May;141(4):413-22. doi: 10.1111/j.1365-2141.2008.07079.x. Review.

PMID:
18318757
8.

Response evaluation and monitoring of multiple myeloma.

Fernández de Larrea C, Delforge M, Davies F, Bladé J.

Expert Rev Hematol. 2014 Feb;7(1):33-42. doi: 10.1586/17474086.2014.876899. Review.

PMID:
24483347
9.

Multiple myeloma: an old disease with new hope for the future.

Zaidi AA, Vesole DH.

CA Cancer J Clin. 2001 Sep-Oct;51(5):273-85; quiz 286-9. Review. Erratum in: CA Cancer J Clin 2002 Jan-Feb;52(1):60.

10.

Treatment of multiple myeloma.

San Miguel JF, Bladé Creixenti J, García-Sanz R.

Haematologica. 1999 Jan;84(1):36-58. Review.

11.

[Classification, staging and prognostic indices for multiple myeloma].

Hotta T.

Nihon Rinsho. 2007 Dec;65(12):2161-6. Review. Japanese.

PMID:
18069256
12.

From myeloma precursor disease to multiple myeloma: new diagnostic concepts and opportunities for early intervention.

Landgren O, Kyle RA, Rajkumar SV.

Clin Cancer Res. 2011 Mar 15;17(6):1243-52. doi: 10.1158/1078-0432.CCR-10-1822. Review.

13.

[Multiple myeloma. Role of prognostic factors and staging in a therapeutic program].

Bolis S, Bregani ER, Rossini F, Casaroli I, Lanzi E, Maffè P, Baldicchi L, Borin L, Mingozzi S, Tripputi P, et al.

Recenti Prog Med. 1994 Jan;85(1):49-55. Review. Italian.

PMID:
8184181
14.

Non-secretory myeloma: a clinician's guide.

Lonial S, Kaufman JL.

Oncology (Williston Park). 2013 Sep;27(9):924-8, 930. Review.

15.

International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders.

Dispenzieri A, Kyle R, Merlini G, Miguel JS, Ludwig H, Hajek R, Palumbo A, Jagannath S, Blade J, Lonial S, Dimopoulos M, Comenzo R, Einsele H, Barlogie B, Anderson K, Gertz M, Harousseau JL, Attal M, Tosi P, Sonneveld P, Boccadoro M, Morgan G, Richardson P, Sezer O, Mateos MV, Cavo M, Joshua D, Turesson I, Chen W, Shimizu K, Powles R, Rajkumar SV, Durie BG; International Myeloma Working Group..

Leukemia. 2009 Feb;23(2):215-24. doi: 10.1038/leu.2008.307. Review.

PMID:
19020545
16.

Role of new treatment approaches in defining treatment goals in multiple myeloma--the ultimate goal is extended survival.

Durie BG.

Cancer Treat Rev. 2010 May;36 Suppl 2:S18-23. doi: 10.1016/S0305-7372(10)70008-6. Review.

PMID:
20472184
17.

[Diagnosis and therapy of multiple myeloma: current aspects].

Betticher DC, Cerny T, Fey MF.

Schweiz Med Wochenschr. 1995 Mar 18;125(11):541-51. Review. German.

PMID:
7899848
18.

International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma.

Kumar S, Paiva B, Anderson KC, Durie B, Landgren O, Moreau P, Munshi N, Lonial S, Bladé J, Mateos MV, Dimopoulos M, Kastritis E, Boccadoro M, Orlowski R, Goldschmidt H, Spencer A, Hou J, Chng WJ, Usmani SZ, Zamagni E, Shimizu K, Jagannath S, Johnsen HE, Terpos E, Reiman A, Kyle RA, Sonneveld P, Richardson PG, McCarthy P, Ludwig H, Chen W, Cavo M, Harousseau JL, Lentzsch S, Hillengass J, Palumbo A, Orfao A, Rajkumar SV, San Miguel J, Avet-Loiseau H.

Lancet Oncol. 2016 Aug;17(8):e328-46. doi: 10.1016/S1470-2045(16)30206-6. Review.

19.

[Necessary diagnostic requirements and therapeutic recommendations in multiple myeloma].

Jurczyszyn A, Zaucha JM, Machaczka M, Grosicki S, Dybko J, Czepiel J, Charliński G, Janda K, Knopińska-Posłuszny W, Skotnicki AB.

Przegl Lek. 2013;70(9):744-53. Review. Polish.

PMID:
24455837
20.

Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1.

Rajkumar SV, Harousseau JL, Durie B, Anderson KC, Dimopoulos M, Kyle R, Blade J, Richardson P, Orlowski R, Siegel D, Jagannath S, Facon T, Avet-Loiseau H, Lonial S, Palumbo A, Zonder J, Ludwig H, Vesole D, Sezer O, Munshi NC, San Miguel J; International Myeloma Workshop Consensus Panel 1..

Blood. 2011 May 5;117(18):4691-5. doi: 10.1182/blood-2010-10-299487.

Items per page

Supplemental Content

Support Center